Vertex Advances Program Targeting Alpha-1 Antitrypsin Deficiency
Go back to Vertex Advances Program Targeting Alpha-1 Antitrypsin Deficiency| Vertex Pharmaceuticals Inc (NASDAQ: VRTX) | Delayed: 496.07 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $496.07 | 52 Week High | $134.71 | |||
| Open | $496.07 | 52 Week Low | $73.31 | |||
| Day High | $496.07 | P/E | N/A | |||
| Day Low | $496.07 | EPS | $-1.98 | |||
| Volume | 52 | |||||
